SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549


                                    FORM 8-K
                CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
                       THE SECURITIES EXCHANGE ACT OF 1934



                          DATE OF REPORT: JUNE 3, 2002


                             COLORADO MEDTECH, INC.
                             ----------------------
             (Exact name of registrant as specified in its charter)


         COLORADO                         000-12471              84-0731006
         --------                         ---------              ----------
(State or other jurisdiction          (Commission File        (I.R.S. Employer
     of incorporation)                     Number)           Identification No.)

                              4801 NORTH 63RD STREET
                             BOULDER, COLORADO 80301
                             -----------------------
          (Address, including zip code, of principal executive offices)


                                 (303) 530-2660
                                 --------------
                         (Registrant's telephone number,
                              including area code)





ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS

         (c) Exhibits.

         No.      Description

         99.1     Investor and analyst presentation materials of the President
                  and Chief Executive Officer and the Chief Financial Officer of
                  Colorado MEDtech, Inc. to be used at meetings with investors
                  and shareholders beginning June 3, 2002 and to be used from
                  time to time thereafter.

ITEM 9. REGULATION FD DISCLOSURE

         On June 3, 2002, the President and Chief Executive Officer and the
company's Chief Financial Officer began meetings with investors, shareholders
and analysts. A copy of the presentation materials that were used at those
meetings and which are to be used from time to time thereafter is filed as
Exhibit 99.1 hereto.



                                      -2-


                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

         DATED, this 3rd day of June, 2002.


                                       COLORADO MEDTECH, INC.


                                       By: /s/ Peter J. Jensen
                                          --------------------------------------
                                          Peter J. Jensen
                                          Vice President



                                      -3-


                                  EXHIBIT INDEX

<Table>
<Caption>
      EXHIBIT
      NUMBER      DESCRIPTION
      -------     -----------
               
      99.1        Investor and analyst presentation materials of the President
                  and Chief Executive Officer and the Chief Financial Officer of
                  Colorado MEDtech, Inc. to be used at meetings with investors
                  and shareholders beginning June 3, 2002 and to be used from
                  time to time thereafter.
</Table>